Buyer

HUS GROUP THE JOINT AUTHORITY FOR HELSINKI AND UUSIMAA

Value published

€10.5m

Across 1 listing

A Finland buyer, with 1 published contract, most recently 12 months ago.

Finland

Value published

€10.5m

Across 1 listing

Contract history

1 entry

26 August 2025

12 months ago · Published · £10,500,000 · Procurement of Nirsevimab for RSV Seaso…

Suppliers

1 on record

SANOFI OY
1 contractlast won 12 months ago
£10.5m
Strongest in Healthcare & Medical

Opportunities

Showing awarded · 1

AwardedHealthcare & MedicalFinland

Procurement of Nirsevimab for RSV Season 2025-2026

The HUS Group is seeking suppliers for the procurement of Nirsevimab (Beyfortus 50 mg and 100 mg injection solution, pre-filled syringe) for use during the respiratory syncytial virus (RSV) epidemic season from October 1, 2025, to March 31, 2026. This medication is intended for infants under 3 month

€10,500,000HUS GROUP THE JOINT AUTHORITY FOR HELSINKI AND UUSIMAA

Published 26 Aug 2025